Literature DB >> 7799963

The yeast TATA-binding protein (TBP) core domain assembles with human TBP-associated factors into a functional TFIID complex.

Q Zhou1, A J Berk.   

Abstract

In mammalian and Drosophila cells, the central RNA polymerase II general transcription factor TFIID is a multisubunit complex containing the TATA-binding protein (TBP) and TBP-associated factors (TAFs) bound to the conserved TBP carboxy-terminal core domain. TBP also associates with alternative TAFs in these cells to form general transcription factors required for initiation by RNA polymerases I and III. Although extracts of human HeLa cells contain little TBP that is not associated with TAFs, free TBP is readily isolated from yeast cell extracts. However, recent studies indicate that yeast TBP can also interact with other yeast polypeptides to form multiprotein complexes. We established stable human HeLa cell lines expressing yeast TBP and several yeast-human TBP hybrids to study TBP-TAF interactions. We found that the yeast TBP core domain assembles with a complete set of human TAFs into a stable TFIID complex that can support activated transcription in vitro. The fact that the yeast TBP core, which differs from human TBP core in approximately 20% of its amino acid residues, has the structural features required to form a stable complex with human TAFs implies that Saccharomyces cerevisiae probably contains TAFs that are structurally and functionally analogous to human TAFs. Surprisingly, the non-conserved amino terminus of yeast TBP inhibited association between the yeast core domain and human TAFs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7799963      PMCID: PMC232007          DOI: 10.1128/MCB.15.1.534

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Functional differences between yeast and human TFIID are localized to the highly conserved region.

Authors:  B P Cormack; M Strubin; A S Ponticelli; K Struhl
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

2.  Dominant negative mutations in yeast TFIID define a bipartite DNA-binding region.

Authors:  P Reddy; S Hahn
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

3.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

4.  A novel mediator between activator proteins and the RNA polymerase II transcription apparatus.

Authors:  R J Kelleher; P M Flanagan; R D Kornberg
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

5.  Analysis of structure-function relationships of yeast TATA box binding factor TFIID.

Authors:  M Horikoshi; T Yamamoto; Y Ohkuma; P A Weil; R G Roeder
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

6.  A highly conserved domain of TFIID displays species specificity in vivo.

Authors:  G Gill; R Tjian
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

7.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Authors:  A J Muller; J C Young; A M Pendergast; M Pondel; N R Landau; D R Littman; O N Witte
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

8.  Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation.

Authors:  B D Dynlacht; T Hoey; R Tjian
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

9.  Two distinct domains in the yeast transcription factor IID and evidence for a TATA box-induced conformational change.

Authors:  P M Lieberman; M C Schmidt; C C Kao; A J Berk
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

10.  Requirement for acidic amino acid residues immediately N-terminal to the conserved domain of Saccharomyces cerevisiae TFIID.

Authors:  Q A Zhou; M C Schmidt; A J Berk
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  9 in total

1.  CTF5--a new transcriptional activator of the NFI/CTF family.

Authors:  S Wenzelides; H Altmann; W Wendler; E L Winnacker
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

2.  Evidence that TAF-TATA box-binding protein interactions are required for activated transcription in mammalian cells.

Authors:  Lisa S Martel; Helen J Brown; Arnold J Berk
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  The Drosophila TATA binding protein contains a strong but masked activation domain.

Authors:  M Um; J L Manley
Journal:  Gene Expr       Date:  2000

4.  Multiple functions of the nonconserved N-terminal domain of yeast TATA-binding protein.

Authors:  M Lee; K Struhl
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

5.  Characterization of the basal inhibitor of class II transcription NC2 from Saccharomyces cerevisiae.

Authors:  A Goppelt; M Meisterernst
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

6.  Inhibition of host transcription by vesicular stomatitis virus involves a novel mechanism that is independent of phosphorylation of TATA-binding protein (TBP) or association of TBP with TBP-associated factor subunits.

Authors:  H Yuan; S Puckett; D S Lyles
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  STD1 (MSN3) interacts directly with the TATA-binding protein and modulates transcription of the SUC2 gene of Saccharomyces cerevisiae.

Authors:  T S Tillman; R W Ganster; R Jiang; M Carlson; M C Schmidt
Journal:  Nucleic Acids Res       Date:  1995-08-25       Impact factor: 16.971

8.  Yeast TATA binding protein interaction with DNA: fluorescence determination of oligomeric state, equilibrium binding, on-rate, and dissociation kinetics.

Authors:  G M Perez-Howard; P A Weil; J M Beechem
Journal:  Biochemistry       Date:  1995-06-27       Impact factor: 3.162

9.  The coactivator p15 (PC4) initiates transcriptional activation during TFIIA-TFIID-promoter complex formation.

Authors:  K Kaiser; G Stelzer; M Meisterernst
Journal:  EMBO J       Date:  1995-07-17       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.